Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018

世界の分子診断市場(~2018)

◆タイトル:Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018
◆商品コード:Markets-MD-2521
◆調査・発行会社:MarketsandMarkets
◆発行日:2014年6月
◆ページ数:299
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single userUSD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User(~5名)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate licence (社内共有可) USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"世界の分子診断市場(~2018)"について調査・分析し、イントロダクション、エグゼクティブサマリー、市場概観、市場の動態、技術別分析、製品別分析、用途別分析、地域別分析、市場規模及び予測、競争状況、市場シェア分析、新製品発売、主要企業(ベンダー)分析等の情報をお届けいたします。

Molecular diagnostics (MDx) has emerged as one of the largest and fastest growing segments in the In vitro Diagnostic (IVD) industry. In the span of few years, molecular diagnostics has prospered from a non-existent market to a significant market. PCR tests such as the one from Roche for CT/NG and other tests such as HIV qualitative and HIV quantitative (viral load) are the key factors driving the expansion of the molecular diagnostics market. The private reference laboratories developed tests for infectious diseases and cancer mutations due to the rising incidences and the non-availability of FDA approved assays. The market began to expand due to the existence of different diagnostic kits for genetic diseases and the blood screening for various infectious diseases. The demand for molecular testing increased and the FDA approved molecular diagnostic tests for determining genetic variation responses against cancer drugs. As a result, molecular diagnostic testing is growing at a rapid rate due to the rising adoption of rapid and quick diagnosis.
The reagents product segment accounted for the largest share of the total molecular diagnostics market in 2013 and will continue to grow in the next five years to retain its leading position. The high growth in this segment is attributed to the growing demand for molecular assays. Moreover, the rising incidences of infectious diseases such as HBV, HIV, CT/NG, and MRSA have also contributed to the largest share of the reagents market. The hospitals end user segment accounted for the second largest share in 2013. This segment can monitor various physiological parameters of a patient in order to have an overview of the patients’ health and status. Due to the tremendous increase in the number of infectious diseases, hospitals are increasing their investments in molecular diagnostic testing.
The PCR technology segment, on the other hand, will be the fastest growing segment in the coming years due to the evolution in technology that helps in diagnosis of various diseases. With the growing incidences and increasing awareness of various diseases this market is set to grow at a faster pace. Under this segment, the INAAT segment is also expected to grow at a higher pace in the forecast period. The microarray technology is also expected to be among the fastest growing in all other segments of the molecular diagnostics market.
In 2013, North America accounted for the largest share and will retain its leading position by 2018. This growth is attributed to the increasing prevalence of lifestyle diseases and spread of various contagious diseases. Asia is the most lucrative region for molecular diagnostics in the next five years, and is poised to grow at a CAGR of 12.2% in the forecast period. The high population base and the improved purchasing power of patients will drive this market. Moreover, the economic crisis in western countries has propelled the companies to focus on the Asian region, thus leading to the economic growth and rise in the investments in this region, which is further driving the market in a positive direction.
The grey area while estimating the market size was the overlapping nature of the applications segment and while segregating them based on the evaluation of endpoints involved. This was later clarified with the help of various experts that participated in the study.
From an insight perspective, this research report focuses on the qualitative data; market size, share, and growth of various segments and sub-segments; competitive landscape; and company profiles. The qualitative data covers various levels of industry analysis, such as market dynamics (drivers, restraints, opportunities, and threats) and technological trends, globally. It also focuses on the emerging and high-growth segments of the molecular diagnostics market and the initiatives of their respective governments.
The competitive landscape covers the growth strategies adopted by the industry players in the last three years. The company profiles comprises of the basic views on the key players in the molecular diagnostics market and their product portfolios, developments, and strategies adopted to maintain and increase their market share in the near future.
The above mentioned market research data, current market size, and forecast of the future trends will help the key players and new entrants to make necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

【レポートの目次】

Table Of Contents

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Market Size Estimation & Data Triangulation
1.6.2 Key Data From Secondary Sources
1.6.3 Key Data Points From Primary Sources
1.6.4 Assumptions

2 Executive Summary (Page No. – 28)

3 Premium Insight (Page No. – 32)

4 Market Overview (Page No. – 41)
4.1 Introduction
4.2 Market Segmentation
4.3 Market Dynamics
4.3.1 Drivers
4.3.1.1 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
4.3.1.2 Development of Biomarker Identification and Advancements in Molecular Techniques
4.3.1.3 Proteomics and Genomics Technology Research to Goad the Molecular Testing Market
4.3.1.4 Increase in AGing Population to Spur Growth of the Molecular Diagnostics Market
4.3.1.5 Reformations in the Reimbursement System
4.3.2 Restraints
4.3.2.1 Increased Costs of Molecular Diagnostics tools With New and Complex Platforms Demand Skilled Labor and Mandatory Training
4.3.2.2 Reimbursement Issues
4.3.2.3 Complex Regulatory Framework to Delay Approvals of New Molecular Diagnostic Tests
4.3.3 Opportunities
4.3.3.1 Extending the Reach of Molecular Diagnostics
4.3.3.2 Emerging Technologies Can Soon Gain Importance in Molecular Diagnostic Tests
4.3.4 Threats
4.3.4.1 Lack of Budget and Labor
4.3.4.2 Stringent Regulatory Framework to Stifle the Growth of Mdx Market
4.4 Market Share Analysis
4.5 Molecular Diagnostic Laboratories and Tests
4.6 End-User Analysis
4.7 Effects of Obamacare on the Molecular Diagnostics Market

5 Global Molecular Diagnostics Market, By Application (Page No. – 57)
5.1 Introduction
5.2 Infectious Diseases
5.2.1 Hepatitis B Virus (HBV)
5.2.2 Hepatitis C Virus (HCV)
5.2.3 Human Immunodeficiency Virus (HIV)
5.2.4 Tuberculosis (TB)
5.2.5 Chlamydia Trachomatis and Neisseria Gonorrhea (CT/NG)
5.2.6 Human Papillomavirus (HPV)
5.2.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)
5.2.8 Others
5.3 oncology
5.3.1 Prostate Cancer
5.3.2 Breast Cancer
5.3.3 Colorectal Cancer
5.3.4 Others
5.4 Genetics
5.5 Blood Screening
5.6 Microbiology
5.7 Others

6 Global Molecular Diagnostics Market, By Technology (Page No. – 76)
6.1 Introduction
6.2 Polymerase Chain Reaction (PCR)
6.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
6.4 Microarrays
6.5 Hybridization (in Situ Hybridization and Fluorescence in Situ Hybridization)
6.6 Dna Sequencing & Next-Generation Sequencing
6.7 Others

7 Global Molecular Diagnostics Market, By Product Type (Page No. – 89)
7.1 Introduction
7.2 Instruments
7.3 Reagents
7.4 Services & Software

8 Geographic Analysis (Page No. – 97)
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 U.K.
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia
8.4.1 Japan
8.4.2 India
8.4.3 China
8.4.4 Rest of Asia (ROA)
8.5 Rest of the World (ROW)
8.5.1 Latin America
8.5.2 Pacific
8.5.3 Middle East & Africa

9 Competitive Landscape (Page No. – 164)
9.1 Introduction
9.2 New Product Launch
9.3 Mergers & Acquisitions
9.4 Agreement/Partnership/Collaboration
9.5 Expansion
9.6 Other Developments

10 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. – 203)
10.1 Abbott Diagnostics, Inc.
10.2 Beckman Coulter, Inc.
10.3 Becton, Dickinson & Co.
10.4 Biomérieux Business Overview
10.5 Cepheid, Inc.
10.6 Gen-Probe, Inc. (Hologic, Inc.)
10.7 Novartis AG
10.8 Qiagen
10.9 Roche Diagnostics
10.1 Siemens Healthcare

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

List of Tables (92 Tables)

Table 1 Molecular Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 2 Global Market, By Application, 2011–2018 ($Million)
Table 3 Total Number of Molecular Diagnostic Laboratories, By Region 2011-2018
Table 4 Total Number of Molecular Diagnostic Tests, By Region 2011-2018, (Millions)
Table 5 Global Molecular Diagnostics Market Size, By End User, 2011–2018 ($Million)
Table 6 Global Molecular Diagnostics Market Size, By Application, 2011–2018 ($Million)
Table 7 Global Infectious Diseases Molecular Diagnostics Market Size, By Type of Disease, 2011–2018 ($Million)
Table 8 Infectious Diseases Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 9 Global Oncology Molecular Diagnostics Market Size, By Type, 2011–2018 ($Million)
Table 10 Oncology Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 11 Genetics Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 12 Blood Screening Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 13 Microbiology Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 14 Other Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 15 Global Molecular Diagnostics Market Size, By Technology, 2011–2018 ($Million)
Table 16 PCR Technology Market Size, By Region, 2011–2018 ($Million)
Table 17 INAAT Market Size, By Region, 2011–2018 ($Million)
Table 18 Microarray Technology Market Size, By Region, 2011–2018 ($Million)
Table 19 Hybridization Technology Market Size, By Region, 2011–2018 ($Million)
Table 20 Dna Sequencing & Ngs Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 21 Other Molecular Diagnostics Technologies Market Size,By Region, 2011–2018 ($Million)
Table 22 Global Molecular Diagnostics Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 23 Molecular Diagnostics Instruments Market Size, By Region, 2011–2018 ($Million)
Table 24 Molecular Diagnostics Reagents Market Size, By Region, 2011–2018 ($Million)
Table 25 Molecular Diagnostics Services & Software Market Size, By Region, 2011–2018 ($Million)
Table 26 Molecular Diagnostics Market Size, By Geography, 2011–2018 ($Million)
Table 27 North America: Molecular Diagnostics Market Size, By Country, 2011–2018 ($Million)
Table 28 North America: Market Size, By Application, 2011–2018 ($Million)
Table 29 North America: Market Size, By Technology, 2011–2018 ($Million)
Table 30 North America: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 31 U.S.: Molecular Diagnostics Market Size, By Application, 2011–2018 ($Million)
Table 32 U.S.: Market Size, By Technology, 2011–2018 ($Million)
Table 33 U.S.: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 34 Canada: Market Size, By Application, 2011–2018 ($Million)
Table 35 Canada: Market Size, By Technology, 2011–2018 ($Million)
Table 36 Canada: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 37 Europe: Market Size, By Country, 2011–2018 ($Million)
Table 38 Europe: Market Size, By Application, 2011–2018 ($Million)
Table 39 Europe: Market Size, By Technology, 2011–2018 ($Million)
Table 40 Europe: Market, By Type of Product & Service, 2011–2018 ($Million)
Table 41 U.K.: Market Size, By Application, 2011–2018 ($Million)
Table 42 U.K.: Market Size, By Technology, 2011–2018 ($Million)
Table 43 U.K.: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 44 Germany: Market Size, By Application, 2011–2018 ($Million)
Table 45 Germany: Market Size, By Technology, 2011–2018 ($Million)
Table 46 Germany: Market, By Type of Product & Service, 2011–2018 ($Million)
Table 47 France: Market Size, By Application, 2011–2018 ($Million)
Table 48 France: Market Size, By Technology, 2011–2018 ($Million)
Table 49 France: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 50 Italy: Market Size, By Application, 2011–2018 ($Million)
Table 51 Italy: Market Size, By Technology, 2011–2018 ($Million)
Table 52 Italy: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 53 Spain: Market Size, By Application, 2011–2018 ($Million)
Table 54 Spain: Market Size, By Technology, 2011–2018 ($Million)
Table 55 Spain: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 56 Rest of Europe: Market Size, By Application, 2011–2018 ($Million)
Table 57 Rest of Europe: Market Size, By Technology, 2011–2018 ($Million)
Table 58 Rest of Europe: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 59 Asia: Market Size, By Region, 2011–2018 ($Million)
Table 60 Asia: Market Size, By Application, 2011–2018 ($Million)
Table 61 Asia: Market Size, By Technology, 2011–2018 ($Million)
Table 62 Asia: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 63 Japan: Market Size, By Application, 2011–2018 ($Million)
Table 64 Japan: Market Size, By Technology, 2011–2018 ($Million)
Table 65 Japan: Market Size, By Product&Service Type, 2011–2018 ($Million)
Table 66 India: Market Size, By Application, 2011–2018 ($Million)
Table 67 India: Market Size, By Technology, 2011–2018 ($Million)
Table 68 India: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 69 China: Market Size, By Application, 2011–2018 ($Million)
Table 70 China: Market Size, By Technology, 2011–2018 ($Million)
Table 71 China: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 72 ROA: Molecular Diagnostics Market Size, By Application, 2011–2018 ($Million)
Table 73 ROA: Market Size, By Technology, 2011–2018 ($Million)
Table 74 ROA: Market Size, By Type of Product & Services, 2011–2018 ($Million)
Table 75 ROW: Market Size, By Region, 2011–2018 ($Million)
Table 76 ROW: Market Size, By Application, 2011–2018 ($Million)
Table 77 ROW: Market Size, By Technology, 2011–2018 ($Million)
Table 78 ROW: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 79 Latin America: Market Size, By Application, 2011–2018 ($Million)
Table 80 Latin America: Market Size, By Technology, 2011–2018 ($Million)
Table 81 Latin America: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 82 Pacific: Market Size, By Application, 2011–2018 ($Million)
Table 83 Pacific: Market Size, By Technology, 2011–2018 ($Million)
Table 84 Pacific: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 85 Middle East & Africa: Molecular Diagnostics Market Size, By Application, 2011–2018 ($Million)
Table 86 Middle East & Africa: Market Size, By Technology, 2011–2018 ($Million)
Table 87 Middle East & Africa: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 88 New Product Launch(2011-2014)
Table 89 Mergers & Acquisitions (2011-2014)
Table 90 Agreement/Partnership/Collaboration(2011-2014)
Table 91 Expansion(2011-2012)
Table 92 Other Developments(2011-2014)

List of Figures (18 Figures)

Figure 1 Market Size Estimation and Data Triangulation
Figure 2 Forecast Model
Figure 3 Global Molecular Diagnostics Market, By Technology, 2013–2018 ($Million)
Figure 4 Global Moleculer Diagnostics Market, 2011-2018 ($Million)
Figure 5 Market Dynamics
Figure 6 Market Snapshot, 2013 ($Million)
Figure 7 Global Market Share Analysis, By Application, 2013 & 2018
Figure 8 Opportunity Matrix, Global Market Size, By Technology, 2013
Figure 9 Global Market, By End-User, 2013 & 2018 ($Million)
Figure 10 Global Market Share Analysis, By Product 2013
Figure 11 Global Molecular Diagnostics Market
Figure 12 Global Market, Share Analysis, 2013
Figure 13 Global Market, By End User, 2013 ($Million)
Figure 14 Opportunity Matrix, Global Market, By Application, 2013
Figure 15 Global Market Share Analysis, By Technology (2013 & 2018)
Figure 16 Global Market Size, By Product, 2018 ($Million)
Figure 17 Molecular Diagnostics Market, Geographic Analysis, By Application 2013 ($Million)
Figure 18 Key Growth Strategies, Molecular Diagnostics Market, 2011–2018

【レポートのキーワード】

分子診断、PCR、INAAT、DNAシークエンシング、治療

★調査レポート[世界の分子診断市場(~2018)] ( Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018 / Markets-MD-2521) 販売に関する免責事項
[世界の分子診断市場(~2018)] ( Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018 / Markets-MD-2521) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆